Literature DB >> 28285848

Utility of serum YKL-40 levels for identification of patients with asthma and COPD.

Yasuhiro Gon1, Shuichiro Maruoka2, Reiko Ito2, Kenji Mizumura2, Yutaka Kozu2, Hisato Hiranuma2, Tomohiro Hattori2, Mai Takahashi2, Mari Hikichi2, Shu Hashimoto2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28285848     DOI： 10.1016/j.alit.2017.02.010

Source DB:  PubMed          Journal:  Allergol Int        ISSN： 1323-8930            Impact factor:   5.836


× No keyword cloud information.
  3 in total

Review 1.  Association between YKL-40 and asthma: a systematic meta-analysis.

Authors:  Yihan Jin; Jie Song; Fang Xu; Di Zhang; Jinfang He; Jiakun Zheng; Yanan Zhang; Jintong Li; Yikun Guo; Mengjiao Xu; Xiangfeng Yu; Yanbin Liu; Qinghua Liu; Jun Yan
Journal:  Sleep Breath       Date:  2021-10-16       Impact factor: 2.655

Review 2.  ACO (Asthma-COPD Overlap) Is Independent from COPD, a Case in Favor: A Systematic Review.

Authors:  Naoya Fujino; Hisatoshi Sugiura
Journal:  Diagnostics (Basel)       Date:  2021-05-11

3.  Plasma YKL-40 and NGAL are useful in distinguishing ACO from asthma and COPD.

Authors:  Jing Wang; Huajie Lv; Zhuang Luo; Shan Mou; Jing Liu; Chang Liu; Shiying Deng; Youfan Jiang; Jiachen Lin; Chengzhou Wu; Xianhong Liu; Jinzhi He; Depeng Jiang
Journal:  Respir Res       Date:  2018-03-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.